Stay updated on PF-06463922 ALK/ROS1 Inhibitor Clinical Trial
Sign up to get notified when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.

Latest updates to the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page
- ChecktodayChange DetectedA new revision entry (v3.6.2) is now shown in the page history, replacing the prior v3.6.0 entry. The update reflects a version bump of the page itself rather than substantive changes to the study information.SummaryDifference0.0%

- Check14 days agoChange DetectedA new history entry for version 3.6.0 is added and a 'No longer looking for participants' note appears, while the 'Revision: v3.5.5' text is removed from the history.SummaryDifference0.2%

- Check22 days agoChange DetectedThe page metadata was updated from v3.5.4 to v3.5.5, indicating a new release of the page. This update does not modify study data, results, or visible content.SummaryDifference0.0%

- Check43 days agoChange DetectedThe revision tag changed from v3.5.3 to v3.5.4, indicating a new release version. This update records the deployment change and does not alter the page’s substantive content or data.SummaryDifference0.0%

- Check65 days agoChange DetectedUpdated the ClinicalTrials.gov page build/version indicator from “Revision: v3.5.2” to “Revision: v3.5.3.” This reflects a site update rather than a change to the underlying trial record history.SummaryDifference0.0%

- Check72 days agoChange DetectedAdded revision label v3.5.2 to the history and removed the v3.5.0 entry.SummaryDifference0.0%

Stay in the know with updates to PF-06463922 ALK/ROS1 Inhibitor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.